Capital Stock Repurchase Plan Transactions

6 Months Ended

Jun. 30, 2020

Capital Stock Repurchase Plan Transactions [Abstract]

Capital Stock Repurchase Plan Transactions

15.    Capital Stock Repurchase Plan Transactions

We repurchased the following capital stock:

	Three months ended June 30,				Six months ended June 30,
	2020		2019		2020		2019
Total cost of repurchased shares (in thousands)	$	21,914	$	22,676	$	122,148	$	71,926
Shares repurchased		50,000		69,009		275,000		219,009
Weighted average price per share	$	438.27	$	328.59	$	444.18	$	328.41

In March 2020, the Board of Directors authorized an additional $250.0 million for stock repurchase under Chemed’s existing share repurchase program. We currently have $231.9 million of authorization remaining under this share repurchase plan.